tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide

C74H68Cl3FN16O11 — CID 158749839

IUPACtert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide
SMILESCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)OC(C)(C)C)c2nc1C
InChIInChI=1S/C26H24ClFN6O3.C26H26ClN5O4.C22H18ClN5O4/c1-14-15(2)32-22-18-8-19(24(36)30-9-16-4-6-17(27)7-5-16)25(37)34(23(18)29-10-20(22)31-14)11-21(35)33-12-26(3,28)13-33;1-14-15(2)31-22-18-10-19(24(34)29-11-16-6-8-17(27)9-7-16)25(35)32(13-21(33)36-26(3,4)5)23(18)28-12-20(22)30-14;1-11-12(2)27-19-15-7-16(21(31)25-8-13-3-5-14(23)6-4-13)22(32)28(10-18(29)30)20(15)24-9-17(19)26-11/h4-8,10H,9,11-13H2,1-3H3,(H,30,36);6-10,12H,11,13H2,1-5H3,(H,29,34);3-7,9H,8,10H2,1-2H3,(H,25,31)(H,29,30)
InChIKeyINIJOLPVJWZJTE-UHFFFAOYSA-N
MW1482.82 g/mol
LogP9.62
Rot. Bonds15

About tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide

tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide (PubChem CID 158749839) has the molecular formula C74H68Cl3FN16O11 and a molecular weight of 1482.82 g/mol. Its IUPAC name is tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide.

Molecular Properties

Compound Nametert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide
PubChem CID158749839
Molecular FormulaC74H68Cl3FN16O11
Molecular Weight1482.82 g/mol
Exact Mass1480.43
IUPAC Nametert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide
SMILESCc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)OC(C)(C)C)c2nc1C
InChIInChI=1S/C26H24ClFN6O3.C26H26ClN5O4.C22H18ClN5O4/c1-14-15(2)32-22-18-8-19(24(36)30-9-16-4-6-17(27)7-5-16)25(37)34(23(18)29-10-20(22)31-14)11-21(35)33-12-26(3,28)13-33;1-14-15(2)31-22-18-10-19(24(34)29-11-16-6-8-17(27)9-7-16)25(35)32(13-21(33)36-26(3,4)5)23(18)28-12-20(22)30-14;1-11-12(2)27-19-15-7-16(21(31)25-8-13-3-5-14(23)6-4-13)22(32)28(10-18(29)30)20(15)24-9-17(19)26-11/h4-8,10H,9,11-13H2,1-3H3,(H,30,36);6-10,12H,11,13H2,1-5H3,(H,29,34);3-7,9H,8,10H2,1-2H3,(H,25,31)(H,29,30)
InChIKeyINIJOLPVJWZJTE-UHFFFAOYSA-N
XLogP9.62
TPSA353.22 Ų
H-Bond Donors4
H-Bond Acceptors22
Rotatable Bonds15
Heavy Atoms105
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001482.82
LogP ≤ 59.62
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The IUPAC name of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide (CID 158749839) is tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide.
What is the SMILES notation for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The canonical SMILES for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide is Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)N3CC(C)(F)C3)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)O)c2nc1C.Cc1nc2cnc3c(cc(C(=O)NCc4ccc(Cl)cc4)c(=O)n3CC(=O)OC(C)(C)C)c2nc1C.
What is the InChIKey of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
The InChIKey is INIJOLPVJWZJTE-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24ClFN6O3.C26H26ClN5O4.C22H18ClN5O4/c1-14-15(2)32-22-18-8-19(24(36)30-9-16-4-6-17(27)7-5-16)25(37)34(23(18)29-10-20(22)31-14)11-21(35)33-12-26(3,28)13-33;1-14-15(2)31-22-18-10-19(24(34)29-11-16-6-8-17(27)9-7-16)25(35)32(13-21(33)36-26(3,4)5)23(18)28-12-20(22)30-14;1-11-12(2)27-19-15-7-16(21(31)25-8-13-3-5-14(23)6-4-13)22(32)28(10-18(29)30)20(15)24-9-17(19)26-11/h4-8,10H,9,11-13H2,1-3H3,(H,30,36);6-10,12H,11,13H2,1-5H3,(H,29,34);3-7,9H,8,10H2,1-2H3,(H,25,31)(H,29,30).
What are the key properties of tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide?
tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide has a molecular weight of 1482.82 g/mol, XLogP of 9.62, 15 rotatable bonds, 4 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetate;2-[9-[(4-chlorophenyl)methylcarbamoyl]-2,3-dimethyl-8-oxopyrazino[2,3-f][1,8]naphthyridin-7-yl]acetic acid;N-[(4-chlorophenyl)methyl]-7-[2-(3-fluoro-3-methylazetidin-1-yl)-2-oxoethyl]-2,3-dimethyl-8-oxopyrazino[2,3-c][1,8]naphthyridine-9-carboxamide is sourced from PubChem (CID 158749839), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).